Results 111 to 120 of about 27,553,759 (265)

National Woman's Party postcard

open access: yes
This is a postcard depicting the Assembly and Reception Rooms within the National Woman's Party Headquarters building in Washington, D.C. The National Woman's Party announced that the house would be the new national headquarters for the party in May ...
National Woman's Party
core  

Excerpt, Oral History Interview, Kaz Nomura

open access: yes, 1994
Excerpt, summary, and index of an oral history interview of Kaz Nomura. Conducted by Lisa Hirai Tsuchitani, K. Tsunomori, and Jere Takahashi on April 29, 1994, in Foster City, CA.
Kaz Nomura   +1 more
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Transformation of peasant migrations: from otkhodnichestvo to organized recruitment

open access: yesВестник Тамбовского университета. Серия: Гуманитарные науки
Importance. In the 1920s–1930s, the USSR underwent a radical transformation of the labor market regulation system: from the liberal mechanisms of free hiring during the New Economic Policy (NEP) to strict centralized control over the movement and use of ...
N. A. Potapova
doaj   +1 more source

Excerpt, Oral History Interview, Ernest Takahashi

open access: yes, 1993
Excerpt, summary, and index of an oral history interview of Ernest Takahashi. Conducted by Lisa Hirai, Marcy Mamiya, and Chizu Iiyama on November 16, 1993.
Lisa Hirai, Marcy Mamiya, Chizu Iiyama   +1 more
core  

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Excerpt, Oral History Interview, Harry Ueno

open access: yes
Excerpt, summary, and index of an oral history interview of Harry Ueno. Interviewer unknown. Transcribed by Yi-Shen Loo.This oral history interview was conducted for the MIS Oral History Project by the Military Intelligence Service Association of ...
Harry Ueno
core  

Home - About - Disclaimer - Privacy